Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Dr. Nikole Kimes is Founder and Chief Scientific Officer of Siolta Therapeutics, a San Francisco-based biotech company developing novel microbiome-focused precision strategies for the prevention and treatment of inflammatory diseases. As the lead executive driving Siolta’s early-stage development, Dr. Kimes leads a talented team of scientists, blending microbiology, immunology, and bioinformatics expertise to leverage microbiome data for the improvement of patient stratification and development of precision microbial therapeutics. Dr. Kimes has over a decade of research experience in microbial ecology and host/microbe interactions, supported by a National Science Foundation Fellowship, an European Commission FP7 cooperative project, and a postdoctoral scholar position at UCSF. An inventor of Siolta’s technology, her research in Dr. Susan Lynch’s lab at UCSF provided the foundation from which the translational research program at Siolta Therapeutics has developed.